Provided by Tiger Trade Technology Pte. Ltd.

Pyxis Oncology, Inc.

3.33
-0.0800-2.35%
Post-market: 3.330.00000.00%19:54 EDT
Volume:564.35K
Turnover:1.89M
Market Cap:277.75M
PE:-2.37
High:3.44
Open:3.38
Low:3.33
Close:3.41
52wk High:5.55
52wk Low:1.03
Shares:83.41M
Float Shares:49.56M
Volume Ratio:0.82
T/O Rate:1.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4029
EPS(LYR):-1.2813
ROE:-179.10%
ROA:-62.95%
PB:24.28
PE(LYR):-2.60

Loading ...

Buy Rating Reiterated on MICVO’s Differentiated Profile and 2026 Data Catalysts; $6 Price Target Maintained

TIPRANKS
·
Aug 15

Analysts Are Bullish on Top Healthcare Stocks: BridgeBio Pharma (BBIO), Pyxis Oncology (PYXS)

TIPRANKS
·
Aug 14

Pyxis Oncology (PYXS) Gets a Buy from Wells Fargo

TIPRANKS
·
Aug 14

Pyxis Oncology Faces Mounting Dilution Risk as Ongoing Equity Raises and Warrants Pressure Shareholder Value

TIPRANKS
·
Aug 14

Genelux Posts Wider-than-Expected Q2 Loss on Higher R&D Expenses

Reuters
·
Aug 14

NuCana Q2 Loss Narrows as Clinical Milestones Remain on Track

Reuters
·
Aug 14

Analysts Have Conflicting Sentiments on These Healthcare Companies: Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxis Oncology (PYXS)

TIPRANKS
·
Aug 14

U.S. Stocks on the MOVE-EnerSys, Netflix, Salesforce

Reuters
·
Aug 14

Pyxis Oncology Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Pyxis Oncology Falls After Wider-than-Expected Quarterly Loss

Reuters
·
Aug 13

Pyxis Oncology Posts Corporate Deck Spotlighting MICVO Extracellular-Targeting ADC in Head-and-Neck Cancer

Reuters
·
Aug 13

Pyxis Oncology Q2 Loss Widens on Increased Administrative Costs

Reuters
·
Aug 13

Pyxis Oncology Q2 EPS $(0.40) Misses $(0.35) Estimate

Benzinga Earnings
·
Aug 13

Pyxis Oncology Q2 Net Income USD -25.346 Million

Reuters
·
Aug 13

Pyxis Oncology Q2 Operating Expenses USD 25.99 Million

THOMSON REUTERS
·
Aug 13

Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances Micvo Toward Key 2026 Clinical Milestones

THOMSON REUTERS
·
Aug 13

Press Release: Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones

Dow Jones
·
Aug 13

NASDAQ Trade Halt Volatility Trading Pause at 12:27 Pm

Reuters
·
Aug 12

Pyxis Oncology Inc Expected to Post a Loss of 35 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Pyxis Oncology Initiated at Overweight by Wells Fargo

Dow Jones
·
Aug 03